Literature DB >> 1062804

Structure of HLA antigens: amino-acid and carbohydrate compositions and NH2-terminal sequences of four antigen preparations.

C Terhorst, P Parham, D L Mann, J L Strominger.   

Abstract

Amino-acid and carbohydrate compositions in addition to limited NH2-terminal sequence data of four preparations of HLA antigens, including products of both of the major histocompatibility loci (HLA-A and HLA-B), show that the antigens have great homology in the primary structure. A striking observation is that HLA antigens also have a considerable structure homology with mouse H-2 antigens. HLA antigens appear to have one carbohydrate side chain which has the same composition in all four cases. The possible relation of the structure of the heavy chain of HLA antigens to immunoglobulins is discussed, based on the limited data which are available so far.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1062804      PMCID: PMC336029          DOI: 10.1073/pnas.73.3.910

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 2.  The immunoglobulin-like structure of human histocompatibility antigens.

Authors:  J L Strominger; P Cresswell; H Grey; R E Humphreys; D Mann; P Parham; R Robb; A R Sanderson; T A Springer; C Terhorst; M J Turner
Journal:  Transplant Rev       Date:  1974

3.  Heterogeneity of HL-A antigen preparations is due to variable sialic acid content.

Authors:  P Parham; R E Humphreys; M J Turner; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

4.  Amino-terminal sequence analysis of proteins purified on a nanomole scale by gel electrophoresis.

Authors:  A M Weiner; T Platt; K Weber
Journal:  J Biol Chem       Date:  1972-05-25       Impact factor: 5.157

5.  Involvement of carbohydrate in the immunochemical determinant area of HL-A substances.

Authors:  A R Sanderson; P Cresswell; K I Welsh
Journal:  Nat New Biol       Date:  1971-03-03

6.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

7.  Partial purification of detergent-soluble HL-A antigen and its cleavage by papain.

Authors:  T A Springer; J L Strominger; D Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

8.  Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane.

Authors:  P Cresswell; T Springer; J L Strominger; M J Turner; H M Grey; R T Kubo
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

9.  Human antigen and enzyme markers in man-Chinese hamster somatic cell hybrids: evidence for synteny between the HL-A, PGM3, ME1, and IPO-B loci.

Authors:  H van Someren; A Westerveld; A Hagemeijer; J R Mees; P Meera Khan; O B Zaalberg
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

10.  The small subunit of HL-A antigens is beta 2-microglobulin.

Authors:  H M Grey; R T Kubo; S M Colon; M D Poulik; P Cresswell; T Springer; M Turner; J L Strominger
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  37 in total

1.  Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents.

Authors:  Sajal K Ghosh; Susan P Perrine; Robert M Williams; Douglas V Faller
Journal:  Blood       Date:  2011-12-07       Impact factor: 22.113

2.  Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells.

Authors:  G Panyi; G Vámosi; Z Bacsó; M Bagdány; A Bodnár; Z Varga; R Gáspár; L Mátyus; S Damjanovich
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

3.  Structure, expression, and molecular mapping of a divergent member of the class I HLA gene family.

Authors:  R Srivastava; M J Chorney; S K Lawrance; J Pan; Z Smith; C L Smith; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

4.  The chemistry of transplantation antigens.

Authors:  R Henning
Journal:  Blut       Date:  1978-04-20

5.  Comparison of amino acid sequences of two human histocompatibility antigens, HLA-A2 and HLA-B7: location of putative alloantigenic sites.

Authors:  H T Orr; J A Lopez de Castro; P Parham; H L Ploegh; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Comparison of rat MHC class I antigens by peptide mapping.

Authors:  D N Misra; H W Kunz; A L Cortese Hassett; T J Gill
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons.

Authors:  S H Speck; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  High-level expression of a cloned HLA heavy chain gene introduced into mouse cells on a bovine papillomavirus vector.

Authors:  D DiMaio; V Corbin; E Sibley; T Maniatis
Journal:  Mol Cell Biol       Date:  1984-02       Impact factor: 4.272

9.  Carbohydrate moieties of rat MHC class I antigens.

Authors:  D N Misra; H W Kunz; T J Gill
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

10.  Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth.

Authors:  E Quackenbush; M Clabby; K M Gottesdiener; J Barbosa; N H Jones; J L Strominger; S Speck; J M Leiden
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.